monoclonal antibodies

Roivant spinout ends development of lung disease asset after phase 2 fail
Fierce Biotech
Tue, 12/3/24 - 11:15 am
Kinevant
Roivant
monoclonal antibodies
namilumab
Dyadic receives grant from Gates Foundation for RSV antibody development
Pharmaceutical Business Review
Fri, 11/22/24 - 11:15 am
Dyadic
Gates Foundation
monoclonal antibodies
RSV
malaria
Respiratory disorder biotech Upstream Bio files for a $100 million IPO
Renaissance Capital
Wed, 09/18/24 - 11:10 pm
Upstream Bio
monoclonal antibodies
IPOs
Respiratory
Immunovant touts positive Phase II batoclimab data as IMVT-1402 also progresses
Clinical Trials Arena
Mon, 09/9/24 - 11:16 am
Immunovant
Graves' disease
IMVT-1402
monoclonal antibodies
clinical trials
Astellas' gastric cancer therapy gets UK regulator's nod
Reuters
Wed, 08/14/24 - 11:19 am
Astellas
UK
gastric cancer
monoclonal antibodies
Vyloy
German biotech CatalYm cashes in on early-stage cancer data with $150M series D
Fierce Biotech
Tue, 07/16/24 - 11:55 am
CatalYm
cancer
monoclonal antibodies
visugromab
funding
Zenas adds $200M series C to reach a bucket of key readouts for its lead monoclonal antibody
Fierce Biotech
Tue, 05/7/24 - 10:58 am
Zenas BioPharma
funding
monoclonal antibodies
obexelimab
autoimmune disease
Roche Plots Neuro Comeback with Promising Mid-Stage Alzheimer’s Data
BioSpace
Tue, 03/12/24 - 11:14 am
Roche
Alzheimer's disease
monoclonal antibodies
RSV monoclonal Beyfortus was 90% effective at preventing hospitalizations in children this winter
Stat
Thu, 03/7/24 - 05:35 pm
Sanofi
AstraZeneca
Beyfortus
RSV
monoclonal antibodies
AbbVie Puts Potential $713M on the Line for OSE’s Inflammation Antibody
BioSpace
Wed, 02/28/24 - 11:12 am
AbbVie
OSE Immunotherapeutics
OSE-230
inflammation
monoclonal antibodies
GSK, Vir end flu drug alliance, removing key piece of $345M pact
Fierce Biotech
Fri, 02/23/24 - 10:30 am
GSK
Vir Biotechnology
Flu
monoclonal antibodies
BioNTech, keeping its powder dry, pays WuXi $20M for 2 preclinical monoclonal antibodies
Fierce Biotech
Thu, 01/11/24 - 11:12 am
BioNTech
monoclonal antibodies
WuXi Biologics
R&D
Sanofi’s Phase III multiple myeloma trial meets primary goal
Clinical Trials Arena
Fri, 12/8/23 - 11:02 am
Sanofi
cliincal trials
Sarclisa
Multiple Myeloma
monoclonal antibodies
Celldex laces up next to Big Pharma players as drug reduces severity of chronic hives
Fierce Biotech
Mon, 11/6/23 - 11:31 am
Celldex Therapeutics
clinical trials
monoclonal antibodies
barzolvolimab
chronic hives
Nascent Biotech to Begin Phase II Clinical Trials for Brain Cancer
BioSpace
Tue, 08/22/23 - 09:44 am
Nascent Biotech
FDA
clinical trials
brain cancer
monoclonal antibodies
CDC advisers endorse RSV monoclonal antibody for infants, high-risk young children
Stat
Thu, 08/3/23 - 06:34 pm
CDC
RSV
infants
monoclonal antibodies
Sanofi
Beyfortus
Evotec's latest DOD contract provides $74M to tackle mpox
Fierce Biotech
Wed, 07/5/23 - 10:32 am
Evotec
mpox
drug development
monoclonal antibodies
Department of Defense
FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV
Stat
Thu, 06/8/23 - 09:47 pm
AstraZeneca
RSV
FDA
monoclonal antibodies
pediatric
Beyfortus
Amgen's denosumab shows promise in small, NIH-funded rare bone disease study
Endpoints
Wed, 04/5/23 - 07:15 pm
Amgen
Prolia
Xgeva
denosumab
clinical trials
NIH
biosimilars
monoclonal antibodies
Reeling from AstraZeneca's termination of pneumonia collab, Aridis lays off 20% of staff
Fierce Biotech
Mon, 04/3/23 - 10:14 am
AstraZeneca
Aridis Pharmaceuticals
MedImmune
monoclonal antibodies
suvratoxumab
layoffs

Pages